KR950007757B1 - 벤족사진 유도체 및 이를 함유하는 약제학적 조성물 - Google Patents

벤족사진 유도체 및 이를 함유하는 약제학적 조성물 Download PDF

Info

Publication number
KR950007757B1
KR950007757B1 KR1019900017951A KR900017951A KR950007757B1 KR 950007757 B1 KR950007757 B1 KR 950007757B1 KR 1019900017951 A KR1019900017951 A KR 1019900017951A KR 900017951 A KR900017951 A KR 900017951A KR 950007757 B1 KR950007757 B1 KR 950007757B1
Authority
KR
South Korea
Prior art keywords
group
groups
lower alkyl
substituted
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900017951A
Other languages
English (en)
Korean (ko)
Other versions
KR910009682A (ko
Inventor
유우조 마쓰모토
류지 스즈끼
아끼라 마쯔히사
카즈히사 다카야마
와타루 우찌다
마사하루 아사노
토루 요덴
이사오 야나기사와
Original Assignee
야마노우치 세이야쿠 가부시키가이샤
모리오카 시게오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마노우치 세이야쿠 가부시키가이샤, 모리오카 시게오 filed Critical 야마노우치 세이야쿠 가부시키가이샤
Publication of KR910009682A publication Critical patent/KR910009682A/ko
Application granted granted Critical
Publication of KR950007757B1 publication Critical patent/KR950007757B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019900017951A 1989-11-08 1990-11-07 벤족사진 유도체 및 이를 함유하는 약제학적 조성물 Expired - Fee Related KR950007757B1 (ko)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP(?)1-290727 1989-11-08
JP29072789 1989-11-08
JP?(?)1-290727? 1989-11-08
JP31592689 1989-12-05
JP?(?)1-315926? 1989-12-05
JP(?)1-315926 1989-12-05
JP(?)1-342937 1989-12-28
JP?(?)1-342937? 1989-12-28
JP34293789 1989-12-28
JP?(?)2-208548? 1990-08-06
JP20854890 1990-08-06
JP(?)2-208548 1990-08-06

Publications (2)

Publication Number Publication Date
KR910009682A KR910009682A (ko) 1991-06-28
KR950007757B1 true KR950007757B1 (ko) 1995-07-14

Family

ID=27476415

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900017951A Expired - Fee Related KR950007757B1 (ko) 1989-11-08 1990-11-07 벤족사진 유도체 및 이를 함유하는 약제학적 조성물

Country Status (11)

Country Link
EP (1) EP0432893A3 (enExample)
JP (1) JPH0774208B2 (enExample)
KR (1) KR950007757B1 (enExample)
AU (1) AU641953B2 (enExample)
FI (1) FI905510A7 (enExample)
HU (1) HU211282A9 (enExample)
IE (1) IE904013A1 (enExample)
NO (1) NO904839L (enExample)
PH (1) PH30439A (enExample)
PT (1) PT95798A (enExample)
TW (1) TW224941B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
JPH06220029A (ja) * 1992-12-03 1994-08-09 Ss Pharmaceut Co Ltd １，４−ベンズオキサジン誘導体
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
WO1994018195A1 (fr) * 1993-02-05 1994-08-18 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de benzoxazine, medicament le contenant, et son intermediaire
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
EP0764639A4 (en) * 1994-06-09 1997-10-01 Ss Pharmaceutical Co 4-CHINOLINONE DERIVATIVE OR ITS SALT
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
WO2002072049A1 (en) * 2001-02-27 2002-09-19 Yamanouchi Pharmaceutical Co., Ltd. Medicinal compositions for stimulating hair growth
WO2002085868A1 (en) * 2001-04-23 2002-10-31 Astrazeneca Ab Benzoxazinone derivatives for use in the treatment of angiogenesis
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
HRP20050089B1 (hr) 2002-07-29 2015-06-19 Rigel Pharmaceuticals Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
JP4886511B2 (ja) 2003-07-30 2012-02-29 ライジェル ファーマシューティカルズ， インコーポレイテッド ２，４−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法
CN100540546C (zh) * 2004-05-05 2009-09-16 弗·哈夫曼-拉罗切有限公司 用于调节5-ht6受体、5-ht2a受体或两者的芳基磺酰基苯并二烷
RU2382036C2 (ru) * 2004-09-30 2010-02-20 Ф.Хоффманн-Ля Рош Аг Производные бензоксазина и хиноксалина и их применение
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
CN101115761B (zh) 2005-01-19 2012-07-18 里格尔药品股份有限公司 2,4-嘧啶二胺化合物的前药及其应用
EP1968940B1 (en) 2005-12-30 2014-04-02 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
EP1985297A1 (en) * 2006-01-27 2008-10-29 Japan Tobacco, Inc. Carboxylic acid compound and use thereof
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
KR101411695B1 (ko) 2006-02-17 2014-07-03 리겔 파마슈티칼스, 인크. 자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물
IN2014CN04174A (enExample) 2011-12-22 2015-09-04 Novartis Ag
CN115181264B (zh) * 2022-07-20 2023-05-23 中国航空工业集团公司济南特种结构研究所 一种苯并噁嗪中间体及其制备方法和聚苯并噁嗪树脂制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595863C3 (de) * 1966-08-11 1978-03-02 Knoll Ag, 6700 Ludwigshafen 4-Piperidinoacetyl-3,4-dihydro-(2H)-l,4-benioxazin und Verfahren zu dessen Herstellung
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
JPS61215381A (ja) * 1985-03-22 1986-09-25 Ube Ind Ltd ベンゾオキサジン誘導体および除草剤
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
EP0290863A3 (en) * 1987-05-09 1989-03-15 Nihon Tokushu Noyaku Seizo K.K. Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide
EP0298542B1 (en) * 1987-07-07 1990-12-12 Shell Internationale Researchmaatschappij B.V. Process for preparing thiophene derivatives
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
IE904013A1 (en) 1991-05-08
PH30439A (en) 1997-05-09
NO904839L (no) 1991-05-10
EP0432893A3 (en) 1991-07-10
AU641953B2 (en) 1993-10-07
PT95798A (pt) 1991-09-13
HU211282A9 (en) 1995-11-28
AU6594790A (en) 1991-06-06
FI905510A0 (fi) 1990-11-07
NO904839D0 (no) 1990-11-07
KR910009682A (ko) 1991-06-28
EP0432893A2 (en) 1991-06-19
FI905510A7 (fi) 1991-05-09
JPH0774208B2 (ja) 1995-08-09
TW224941B (enExample) 1994-06-11
JPH04178375A (ja) 1992-06-25

Similar Documents

Publication Publication Date Title
KR950007757B1 (ko) 벤족사진 유도체 및 이를 함유하는 약제학적 조성물
JP5305914B2 (ja) オキサゾール化合物及び医薬組成物
DE69114052T2 (de) Bicyclische Pyranderivate und ihre Verwendung als 5-Lipoxygenasehemmer.
US5756496A (en) Amide derivatives having 5HT1D-antagonist activity
JPH04243877A (ja) チオキソ複素環式化合物、その製造方法、ロイコトリエンが介在する疾患および症状の治療において使用するためのこの化合物を有する医薬品
JP2013505220A (ja) Ｐ２ｘ７調節薬としての縮合トリアゾールアミン類
US5710152A (en) Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same
JPH0641455B2 (ja) ピリダジノン誘導体
JP4986927B2 (ja) 医薬
JP2840288B2 (ja) 置換１―（１ｈ―イミダゾール―４―イル）アルキル―ベンズアミド
US5179111A (en) Imidazole derivatives
CA2202057C (en) 5-lipoxygenase inhibitors
US5420126A (en) 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical compositions containing the same
WO1993022292A1 (en) New quinazolines as inhibitors of hiv reverse transcriptase
HU199124B (en) Process for producing benzazepine sulfonamides and antiarrhythmic agents comprising these compounds
JP2001519413A (ja) 良性の前立腺過形成の治療に有用な複素環化合物およびそれらの中間体
HU189296B (en) Process for producing oxazole-4-acetic acid derivatives
NZ266541A (en) Imidazole derivatives, intermediate compounds and pharmaceutical compositions
NO180585B (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive benzoksazinon- og benzotiazinonderivater og mellomprodukter
AU616608B2 (en) 4,5,6,7-tetrasubstituted benzoxazolones
US5440036A (en) 1,4-benzoxazine derivatives
US4806560A (en) Imidazo[4,5-b]pyridin-2-one derivatives
JP3400392B2 (ja) ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
EP0192935B1 (en) 3-(piperidinyl)-1h-indazoles a process for their preparation and their use as medicaments
CA2029569A1 (en) Benzoxazine derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19980715

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19980715

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301